BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 2622919)

  • 1. The intravascular persistence of crosslinked human hemoglobin.
    Hess JR; Fadare SO; Tolentino LS; Bangal NR; Winslow RM
    Prog Clin Biol Res; 1989; 319():351-7; discussion 358-60. PubMed ID: 2622919
    [No Abstract]   [Full Text] [Related]  

  • 2. Catabolism and excretion of crosslinked hemoglobin.
    Keipert PE; Triner L
    Prog Clin Biol Res; 1989; 319():383-402; discussion 403-5. PubMed ID: 2622920
    [No Abstract]   [Full Text] [Related]  

  • 3. Development of zero-link polymers of hemoglobin, which do not extravasate and do not induce pressure increases upon infusion.
    Bucci E; Kwansa H; Koehler RC; Matheson B
    Artif Cells Blood Substit Immobil Biotechnol; 2007; 35(1):11-8. PubMed ID: 17364467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravascular circulation and distribution of human 51Cr-DBBF stroma-free hemoglobin.
    Dittmer J; Ichikura T; Pivacek LE; Giorgio A; Prusty S; Valeri CR
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):751-5. PubMed ID: 1391507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of the degree of hemoglobin polymerization on its interaction with the body].
    Azhigirova MA; Vashkevich MG; Kontuganov NN; Loginova LN
    Biull Eksp Biol Med; 1990 Mar; 109(3):262-4. PubMed ID: 2364153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An improved blood substitute. In vivo evaluation of its renal effects.
    Simoni J; Simoni G; Hartsell A; Feola M
    ASAIO J; 1997; 43(5):M714-25. PubMed ID: 9360140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulation kinetics and organ distribution of Hb-vesicles developed as a red blood cell substitute.
    Sou K; Klipper R; Goins B; Tsuchida E; Phillips WT
    J Pharmacol Exp Ther; 2005 Feb; 312(2):702-9. PubMed ID: 15459236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modification of hemoglobin - tetrameric stabilization.
    Tye RW; Medina F; Bolin RB; Knopp GL; Irion GS; McLaughlin SK
    Prog Clin Biol Res; 1983; 122():41-9. PubMed ID: 6878380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Biochemical properties of intramolecularly cross-linked hemoglobin].
    Azhigirova MA; Viazova EP; Vashkevich MG; Fetisova LV; Kontuganov NN
    Biull Eksp Biol Med; 1988 Sep; 106(9):302-4. PubMed ID: 3167181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of sepsis on the plasma elimination pharmacokinetics of diaspirin crosslinked hemoglobin in rats.
    d'Almeida MS; Sibbald WJ; White M; Chin-Yee IH
    Artif Cells Blood Substit Immobil Biotechnol; 1998 May; 26(3):273-84. PubMed ID: 9635120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of the kidneys in the excretion of chemically modified hemoglobins.
    Keipert PE; Gomez CL; Gonzales A; Macdonald VW; Winslow RM
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):737-45. PubMed ID: 1391505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modified haemoglobins as oxygen-transporting blood substitutes.
    Mallick A; Bodenham AR
    Br J Hosp Med; 1996 Apr 3-16; 55(7):443-8. PubMed ID: 8730571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Appearance of dissociable and cross-linked hemoglobins in the renal hilar lymph.
    Matheson B; Razynska A; Kwansa H; Bucci E
    J Lab Clin Med; 2000 Jun; 135(6):459-64. PubMed ID: 10850645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HbXL99 alpha: a hemoglobin derivative that is cross-linked between the alpha subunits is useful as a blood substitute.
    Snyder SR; Welty EV; Walder RY; Williams LA; Walder JA
    Proc Natl Acad Sci U S A; 1987 Oct; 84(20):7280-4. PubMed ID: 3478694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemoglobinuria in rats: a sensitive test of renal filtering and absorption of PEG-hemoglobin, a red blood cell substitute.
    Gilbert C; Nho K; Johnson M; Linberg R; Shorr R
    Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(3):535-41. PubMed ID: 7994375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The transhemenation process of bovine and human hemoglobin polymers under conditions simulating the situation in the circulatory bed].
    Smirnov IV; Khachatur'ian AA
    Biull Eksp Biol Med; 1991 Nov; 112(11):500-1. PubMed ID: 1810487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polyethylene glycol-modified liposome-encapsulated hemoglobin: a long circulating red cell substitute.
    Phillips WT; Klipper RW; Awasthi VD; Rudolph AS; Cliff R; Kwasiborski V; Goins BA
    J Pharmacol Exp Ther; 1999 Feb; 288(2):665-70. PubMed ID: 9918573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulation persistence and biodistribution of lyophilized liposome-encapsulated hemoglobin: an oxygen-carrying resuscitative fluid.
    Rudolph AS; Cliff RO; Klipper R; Goins B; Phillips WT
    Crit Care Med; 1994 Jan; 22(1):142-50. PubMed ID: 8124957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enzymatic protection from autoxidation for crosslinked hemoglobins.
    Yang T; Olsen KW
    Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(3):709-17. PubMed ID: 7994392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute changes in systemic blood pressure and urine output of conscious rats following exchange transfusion with diaspirin-crosslinked hemoglobin solution.
    Keipert PE; Gonzales A; Gomez CL; MacDonald VW; Hess JR; Winslow RM
    Transfusion; 1993 Sep; 33(9):701-8. PubMed ID: 8212113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.